Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

Clinical trial NCT07634770 · RECRUITING

Trial details

NCT number: NCT07634770
Sponsor: Sam Chun Dang Pharm. Co. Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2026-05-29
Primary completion: 2026-10-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.